Constellium Q4 Adj. EPS $0.07 Misses $0.32 Estimate, Sales $1.74B Beat $1.72B Estimate
Portfolio Pulse from Benzinga Newsdesk
Constellium (NYSE:CSTM) reported Q4 adjusted EPS of $0.07, missing the $0.32 estimate by 76.56%, and a 62.5% decrease from last year's $0.20. Sales were $1.74B, beating the $1.72B estimate by 0.93%, but down 7.76% from last year's $1.88B.
February 21, 2024 | 11:07 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Constellium reported a significant miss in Q4 adjusted EPS at $0.07 against a $0.32 estimate and a decrease in sales year-over-year.
The significant miss in EPS and the year-over-year decrease in sales are likely to negatively impact investor sentiment towards CSTM in the short term. Missing analyst estimates by a wide margin can lead to decreased confidence and potential sell-off.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100